Maharashtra, Delhi Among 5 States To Receive First Batch Of COVID-19 Drug | Read

Hyderabad-based drugmaker Hetero, which has approval to manufacture and market the generic version of the experimental COVID-19 drug Remdesivir, has sent 20,000 vials to five states including Maharashtra and Delhi - the two worst affected states in the country.

Related Videos